NuVasive buys back $37 million of its 2.25% convertibles due 2013

By Ashley Montgomery

Kansas City, Kan., Dec. 12 - NuVasive, Inc. repurchased $37 million its 2.25% convertible senior notes due March 2013 in private transactions, according to an 8-K filed with the Securities and Exchange Commission.

The company said it repurchased the notes at 97.9% of the principal amount plus accrued interest, for a total cost of $36.4 million.

The repurchased were funded with proceeds from the company's recent offering of $402.5 million 2.75% convertible senior notes due 2017, the filing said.

As of Dec. 9, $74.3 million of the original $230 million of 2.25% notes remains outstanding.

NuVasive, based in San Diego, develops surgical products and procedures for medical treatment of the spine.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.